Advanced search
Publication Cover
Patient Preference and Adherence Volume 14, 2020 - Issue
Submit an article Journal homepage
125
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Adherence with Medical Therapy for Primary Open-Angle Glaucoma in Kenya – A Pilot Study

Ian Murdoch1 Institute of Ophthalmology, LondonEC1V 9EL, UKCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-5453-0635
ORCID Icon,
David Nyakundi2 Innovation Eye Centre Ltd, Kisii, KenyaORCID Iconhttps://orcid.org/0000-0003-1746-6686
ORCID Icon,
Helen Baker1 Institute of Ophthalmology, LondonEC1V 9EL, UKORCID Iconhttps://orcid.org/0000-0003-2916-9443
ORCID Icon,
Simon Dulku3 University Hospitals Birmingham NHS Foundation Trust, BirminghamB15 2WB, UK
&
Daniel Kiage2 Innovation Eye Centre Ltd, Kisii, Kenya
Pages 221-225 | Published online: 10 Feb 2020

References

  • Available from: https://www.iapb.org/wp-content/uploads/world-vision-report-accessible1.pdf. Accessed December 8, 2019.
  • Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121:2081–2090. doi:10.1016/j.ophtha.2014.05.013
  • Kyari F, Abdull MM, Bastawrous A, Gilbert CE, Faal H. Epidemiology of glaucoma in sub-Saharan Africa: prevalence, incidence and risk factors. Middle East Afr J Ophthalmol. 2013;20:111–125. doi:10.4103/0974-9233.110605
  • The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS investigators. Am J Ophthalmol. 2000;130:429–440. doi:10.1016/S0002-9394(00)00538-9
  • Heijl A, Leske MC, Bengtsson B, Hyman L, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial. Arch Ophthalmol. 2002;120:1268–1279. doi:10.1001/archopht.120.10.1268
  • Kass MA, Heuer DK, Higginbotham EJ, et al. The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701–13; discussion 829–30. doi:10.1001/archopht.120.6.701
  • Available from: https://cks.nice.org.uk/glaucoma#!scenariorecommendation:1.
  • Vélez-Gómez MC 1, Vásquez-Trespalacios EM. Adherence to topical treatment of glaucoma, risk and protective factors: a review. Arch Soc Esp Oftalmol. 2018;93(2):87–92. doi:10.1016/j.oftal.2017.07.012
  • Detry-Morel M. Side effects of glaucoma medications. Bull Soc Belge Ophtalmol. 2006;299:27–40.
  • Adekoya BJ, Adepoju FG, Moshood KF, Balarabe AH. Challenges in the management of glaucoma in a developing country; a qualitative study of providers’ perspectives. Niger J Med. 2015;24(4):315–322.
  • Santos MA, Ayena DK, Kuaovi KR, Vonor K, Djagnikpo A, Balo KP. Adherence with medical treatment in primary open-angle glaucoma in Lomé. J Fr Ophtalmol. 2016;39(5):459–466. doi:10.1016/j.jfo.2015.10.013
  • Tchabi S, Abouki C, Sounouvou I, Yèhouessi L, Doutetien C, Bassabi SK. Observance au traitement médical dans le glaucome primitif à angle ouvert. [Survey of medical treatment in primary open-angle glaucoma]. J Fr Ophtalmol. 2011;34(9):624–628. doi:10.1016/j.jfo.2011.07.009
  • Kyari F, Nolan W, Gilbert C. Ophthalmologists’ practice patterns and challenges in achieving optimal management for glaucoma in Nigeria: results from a nationwide survey. BMJ Open. 2016;6(10). doi:10.1136/bmjopen-2016-012230
  • Tamrat L, Gessesse GW. Gelaw Y Adherence to topical glaucoma medications in Ethiopian patients. Middle East Afr J Ophthalmol. 2015;22(1):59–63. doi:10.4103/0974-9233.148350
  • Abdull MM, Chandler C, Gilbert C. Glaucoma,“the silent thief of sight”: patients’ perspectives and health seeking behaviour in Bauchi, northern Nigeria. BMC Ophthalmol. 2016;21(16):44. doi:10.1186/s12886-016-0220-6
  • Ocansey S, Kyei S, Diafo A, Darfor KN, Boadi-Kusi SB, Aglobitse PB. Cost of the medical management and prescription pattern for primary open angle glaucoma (POAG) in Ghana-a retrospective cross-sectional study from three referral facilities. BMC Health Serv Res. 2016;19(16):282. doi:10.1186/s12913-016-1528-x
  • Mehari T, Giorgis AT, Shibeshi W. Level of adherence to ocular hypotensive agents and its determinant factors among glaucoma patients in Menelik II Referral Hospital, Ethiopia. BMC Ophthalmol. 2016;2(16):131. doi:10.1186/s12886-016-0316-z
  • Sherwood M, Brandt J, for the Bimatoprost Study Groups 1 and 2. Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure. Surv Ophthalmol. 2001;45(S4):S361–S368. doi:10.1016/S0039-6257(01)00219-3
  • Parrish RK, Palmberg P, Sheu WP, XLT Study Group. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. Am J Ophthalmol. 2003;135:688–703. doi:10.1016/S0002-9394(03)00098-9
  • Olthoff C, Schouten J, van de Borne B, Webers C. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension- an evidence based review. Ophthalmology. 2005;112:953–961. doi:10.1016/j.ophtha.2004.12.035
  • Davis S, Sleath B, Carpenter D, Blalock S, Muir K, Budenz D. Drop instillation and glaucoma. Curr.Opin.Ophthalmol. 2018;29:171–177. doi:10.1097/ICU.0000000000000451

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.